Skip to content
WeighLab

iThriveMD vs AbundRX

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

iThriveMD

Provider comparison

Patients in California or Arizona who want clinic access, laboratory testing and ongoing coaching alongside their prescription.

Semaglutide / month
$299 every 28 daysAll doses, compounded; first cycle $199
Tirzepatide / month
$399 every 28 daysAll doses, compounded; first cycle $299
Index 66/100 · Grade CChecked October 2026

AbundRX

Provider comparison

Cost-first shoppers, with the caveat that the advertised price's time period is unconfirmed.

Semaglutide / month
$99/mo'Starting at', no period, dose or supply stated, compounded
Tirzepatide / month
$149/mo'Starting at', no period, dose or supply stated, compounded
Index 65/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

iThriveMD has the higher Cost-Efficiency Index: 66/100 versus 65/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

iThriveMD
2 states (CA, AZ)
AbundRX
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

iThriveMD

AbundRX

Semaglutide / month
iThriveMD: $299 every 28 daysAll doses, compounded; first cycle $199
AbundRX: $99/mo'Starting at', no period, dose or supply stated, compounded
Tirzepatide / month
iThriveMD: $399 every 28 daysAll doses, compounded; first cycle $299
AbundRX: $149/mo'Starting at', no period, dose or supply stated, compounded
Semaglutide / year (modeled)
iThriveMD: $3,88713 charges
AbundRX: $1,188
Tirzepatide / year (modeled)
iThriveMD: $5,18713 charges
AbundRX: $1,788
State availability
iThriveMD: 2 states (CA, AZ)
AbundRX: Coverage not published
Oral / sublingual option listed
iThriveMD: Not listed
AbundRX: Not listed
Brand-name access listed
iThriveMD: Not confirmed
AbundRX: Not confirmed
Provider facts checked
iThriveMD: October 2026
AbundRX: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

iThriveMD

Patients in California or Arizona who want clinic access, laboratory testing and ongoing coaching alongside their prescription.

Reasons to consider it

  • Names physician founder Samir Damani, MD, and its clinical team
  • Publishes the same price at every dose for each injection program
  • Offers a monthly option without a long-term commitment

What to weigh up

  • Standing charges are $299/$399 every 28 days after the $199/$299 first-cycle promotion; continuous treatment has 13 billing cycles a year
  • Optional discounted longer plans require paying for 12, 24 or 48 weeks up front
  • No dispensing pharmacy is named behind the certified-facility claim

AbundRX

Cost-first shoppers, with the caveat that the advertised price's time period is unconfirmed.

Reasons to consider it

  • LegitScript certification badge shown on the homepage
  • Simple, fast online health assessment with two clear compounded GLP-1 pathways
  • Low advertised entry price: $99 semaglutide and $149 tirzepatide on the site's own product cards

What to weigh up

  • The site never says whether $99 and $149 are monthly, one-time or first-order prices, and its intake form says 'Your $120 discount is applied — save on your first month', so they may be discounted first-month figures
  • No dose amount or supply quantity is disclosed for either price
  • No compounding pharmacy is named (503A vs 503B status unclear) and no medical director is named

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

iThriveMDAbundRX
Normalized Cost/Month
iThriveMD:
45/100
AbundRX:
81/100
Price Transparency
iThriveMD:
94/100
AbundRX:
78/100
Nationwide Access
iThriveMD:
42/100
AbundRX:
24/100
Formulation Options
iThriveMD:
66/100
AbundRX:
66/100
Clinical Oversight
iThriveMD:
95/100
AbundRX:
80/100
Contract Flexibility
iThriveMD:
67/100
AbundRX:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.